NCT01632527View on ClinicalTrials.gov

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Age Related Macular DegenerationMacular DegenerationAMD
Interventions
DRUG

HuCNS-SC cells

HuCNS-SC cells transplantation directly into the subretinal space of one eye (Study eye) in a single transplant procedure.

Trial Locations (5)

10003

New York Eye and Ear Infirmary, New York

75231

Retina Foundation of the Southwest, Dallas

79606

Retina Research Institute of Texas, Abilene

90211

Retina-Vitreaous Associates Medical Group, Los Angeles

94303

Byers Eye Institute at Stanford, Stanford Hospital and Clinics, Palo Alto

All Listed Sponsors
lead

StemCells, Inc.

INDUSTRY

NCT01632527 - Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) | Biotech Hunter | Biotech Hunter